Rapid advances in immunotherapy, targeted drugs & artificial intelligence-driven research are reshaping oncology, ...

“By dividing and conquering…we’re seeing responses in multiple different subtypes of sarcoma…and moving toward more of an individualized therapy that we try to design for every patient, where we take ...

A major update appears in the Boxed Warning, the most prominent safety warning required by the FDA. The warning now ...

Ambry Genetics, part of Tempus AI, contributed to research using advanced genetic assays to refine how hereditary cancer variants are interpreted. Ambry also reached a milestone of 1,000,000 combined ...

Providence researchers and physicians are harnessing the power of artificial intelligence to find patterns hidden among ...

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...

Explore how biochemistry, microbiology, and pathology collaborate in cancer care for early detection, personalized treatment, and survival monitoring.

Doctors blame changing lifestyle, unhealthy diets and sedentary habits for the surge. Read more at straitstimes.com. Read ...

The second floor of the Indiana Statehouse was filled with "Warriors" on Monday as more than 1,700 Hoosiers living with ...

Pittet lab A human head-and-neck tumor containing infiltrating neutrophils. Tumor cells appear in light grey. Among the ...

University of Iowa researchers are about a fourth of the way through a state-funded research project examining why Iowa has some of the nation's highest cancer rates.

ADARx Pharmaceuticals has named Donald Fong, MD, its new Chief Medical Officer (CMO). He served in the same post at BioCryst Pharmaceuticals.